Call to waive COVID vaccine patents
-----------------------------------------
The U.S. has joined India and South Africa in calling for a waiver on COVID vaccine patents, to allow any manufacturer in the world to produce their own copies without fear of infringing intellectual property rights
-----------------------------------------
Unlike other major vaccine producers, U.S. reserves most for domestic use
Seychelles 129.88 
UAE 110.28

DOSES PER 100 PEOPLE May 7 
No data 0 1 5 10 20 40 100

Israel 121.18 (includes second doses)
-----------------------------------------
VACCINE PRODUCTION    Doses as of March 3

China Sinovac, Sinopharm, CanSino, Astra Zeneca 141.6 million 
U.S. Pfizer/BioNTech, Moderna 103m
Germany/Belgium/Netherlands 81m Pfizer, AZ
India  42.4m AZ, Bharat
UK 12.2m AZ
Russia 10.5m Sputnik V 
Switzerland 5.5m Moderna
South Korea 1.6m AZ
Brazil 0.2m Sinopharm
South Africa 0.16m J&J 
-----------------------------------------
Germany claims manufacturing capacity and standards are limiting production,
not patents. Pfizer CEO Albert Bourla says theirs are the only facilties that can manufacture mRNA vaccines
-----------------------------------------
Sources: Our World in Data, Airfinity
© GRAPHIC NEWS